YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION

Business Combination to deliver approximately $36 million of gross proceeds YS Biopharma expects to close the Business Combination on March 16, 2023 YS Biopharma Ordinary Shares and YS Biopharma Warrants expected to begin trading on the Nasdaq on March 17, 2023 under the symbols "YS" and "YSBPW," respectively NEW YORK, March 15, 2023 /PRNewswire/ -- YishengBio Co., Ltd...

Related Keywords

China ,Philippines ,United States ,United Arab Emirates ,Singapore ,Cayman Islands ,Wilson Sonsini Goodrich Rosati ,Jingtian Gongcheng ,David Hui Shao ,Calder Hong Kong ,Summit Healthcare Acquisition Sponsor ,Summit Healthcare Acquisition Corp ,Nasdaq ,Exchange Commission ,Prnewswire Yishengbio Co Ltd ,Ys Biopharma Co Ltd ,Business Combination ,Ordinary Shares ,Summit Healthcare Acquisition ,Nasdaq Capital Market ,Chief Executive Officer ,Co Chief Investment Officer ,Sonsini Goodrich ,Hong Kong ,Current Report ,Healthcare Acquisition ,